{"id":10414,"date":"2026-07-25T20:44:10","date_gmt":"2026-07-25T17:44:10","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=10414"},"modified":"2026-07-25T20:44:10","modified_gmt":"2026-07-25T17:44:10","slug":"tavr-outcomes-high-vs-low-volume-hospitals-fewer-complications-but-similar-mortality-after-major-complications","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/tavr-outcomes-high-vs-low-volume-hospitals-fewer-complications-but-similar-mortality-after-major-complications\/","title":{"rendered":"TAVR Outcomes: High- vs Low-Volume Hospitals Fewer complications, but similar mortality after major complications."},"content":{"rendered":"<p><span>TAVR Outcomes: High- vs Low-Volume Hospitals<\/span><br \/>\n<span>Fewer complications, but similar mortality after major complications.<\/span><\/p>\n<p><span>Source: JACC , July 2026.<\/span><\/p>\n<p><span>* Analysis of ~500,000 TAVR patients from 808 U.S. hospitals (2017\u20132023).<\/span><br \/>\n<span>* High-volume centers had lower rates of major complications and 30-day mortality than low-volume centers.<\/span><br \/>\n<span>* However, failure-to-rescue (FTR)\u2014death after a major TAVR complication\u2014was similar across high- and low-volume hospitals (overall FTR \u224811%).<\/span><br \/>\n<span>* The volume\u2013outcome advantage appears to be driven by preventing complications, not by better management once complications occur.<\/span><br \/>\n<span>* Clinical message: Improving prevention of major TAVR complications, including AI-assisted preprocedural planning and adherence to best practices, may help lower-volume centers achieve outcomes closer to experienced high-volume programs.<\/span><\/p>\n<p><a href=\"https:\/\/www.jacc.org\/doi\/10.1016\/j.jcin.2026.03.036\" target=\"_blank\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.jacc.org\/doi\/10.1016\/j.jcin.2026.03.036&amp;source=gmail&amp;ust=1785087762024000&amp;usg=AOvVaw0IsF06I5X3CTJevNli0vC1\" rel=\"noopener\">https:\/\/www.jacc.org\/doi\/10.<wbr \/>1016\/j.jcin.2026.03.036<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>TAVR Outcomes: High- vs Low-Volume Hospitals Fewer complications, but similar mortality after major complications. Source: JACC , July 2026. * Analysis of ~500,000 TAVR patients from 808 U.S. hospitals (2017\u20132023). * High-volume centers had lower rates of major complications and 30-day mortality than low-volume centers. * However, failure-to-rescue (FTR)\u2014death after a major TAVR complication\u2014was similar [&hellip;]<\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-10414","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/10414","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=10414"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/10414\/revisions"}],"predecessor-version":[{"id":10415,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/10414\/revisions\/10415"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=10414"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=10414"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=10414"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}